Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series

BACKGROUND: Omadacycline is an aminomethylcycline antimicrobial approved by the US Food and Drug Administration in 2018 for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections. It has in vitro activity against nontuberculous mycobacteria, including Mycobacte...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Open Forum Infect Dis
Hlavní autoři: Pearson, Jeffrey C, Dionne, Brandon, Richterman, Aaron, Vidal, Samuel J, Weiss, Zoe, Velásquez, Gustavo E, Marty, Francisco M, Sax, Paul E, Yawetz, Sigal
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Major Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7566545/
https://ncbi.nlm.nih.gov/pubmed/33094118
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa415
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky